![](/img/cover-not-exists.png)
Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)
Chouaid Christos, Le Caer Hervé, Locher Chrystelle, Dujon Cecile, Thomas Pascal, Auliac Jean Bernard, Monnet Isabelle, Vergnenegre AlainVolume:
12
Language:
english
DOI:
10.1186/1471-2407-12-301
Date:
December, 2012
File:
PDF, 569 KB
english, 2012